Dr. Wendy E. Hoy is Professor of Medicine and directs the Centre for Chronic Disease at University of Queensland, Australia, and was appointed Officer of the Order of Australia (AO) in 2010 and elected as a member of the Australian Academy of Science in 2015. Her research interests include kidney and related chronic diseases in high-risk populations, including Aboriginal Australians, Native Americans and African Americans. Wendy collaborates on research and capacity-building programs in South Africa, Nigeria and Sri Lanka. She was among the first to describe associations between early-life risk factors and low birth weight with disease susceptibility. She collaborates in studies of identification of structural, ultrastructural and molecular markers of susceptibility to kidney disease, hypertension and cardiovascular disease and participates with the Australian Genome Research Facility and the NIH/NIDDK in genetic studies. Her work has stimulated primary and secondary prevention, and outcome and cost-effectiveness inquiries.
Dr. Wendy E. Hoy is Professor of Medicine and directs the Centre for Chronic Disease at University of Queensland, Australia, and was appointed Officer of the Order of Australia (AO) in 2010 and elected as a member of the Australian Academy of Science in 2015. Her research interests include kidney and related chronic diseases in high-risk populations, including Aboriginal Australians, Native Americans and African Americans. Wendy collaborates on research and capacity-building programs in South Africa, Nigeria and Sri Lanka. She was among the first to describe associations between early-life risk factors and low birth weight with disease susceptibility. She collaborates in studies of identification of structural, ultrastructural and molecular markers of susceptibility to kidney disease, hypertension and cardiovascular disease and participates with the Australian Genome Research Facility and the NIH/NIDDK in genetic studies. Her work has stimulated primary and secondary prevention, and outcome and cost-effectiveness inquiries.